肺脑合剂在基层医院的使用  

Pulmonary Cerebral Mixture in the Use of Basic-Level Hospitals

作　　者：王群超 

机构地区：[1]江苏省邳州市占城镇卫生院,江苏邳州221300

出　　处：《现代医用影像学》2013年第1期77-78,共2页Modern Medical Imageology

摘　　要：目的:观察肺脑合剂治疗肺性脑病的临床疗效。材料与方法:本组32例患者均给予持续低流量吸氧、抗感染等常规治疗,同时给予肺脑合剂:可拉明0.375 g×1～3支、洛贝林3㎎×1～3支、氨茶碱0.125～0.25 g、地塞米松10～30 mg加入250 ml 5%葡萄糖液中,静脉滴注,每日1次,对于病情危重者可加1次。治疗12h后观察疗效。结果:本组32例患者经治疗显效18例,占56.25%;有效12例,占37.50%;无效1例,占3.13%;死亡1例,占3.13%。总有效率93.75%。治疗前后pH值相比差异无统计学意义(P>0.05);PaCO2、PaO2治疗前后相比差异有统计学意义(P<0.05)。结论:肺脑合剂治疗肺性脑病临床疗效显著,可较好的改善临床症状及血气分析状况,且具有简单方便的特点,适宜于在基层医院推广应用。Purpose： Observation pulmonary cerebral mixture treatment of pulmonary encephalopathy clinical curative effect. Materials and Methods： The 32 patients were given continued low flow oxygen, fight infection conventional treatment, at the same time give lung brain mixture ： nikethamide 0. 375 g multiply one - 3 branch, los behring 3 mg multiply one 3 branch, aminophylline 0. 125 -0. 25 g, dexamethasone 10 - 30 mg add 250 ml 5% glucose fluid, drip once a day, for it is an emergency case can be add 1 time. After the treatment of 12 h curative effect observation. Results： The 32 cases were markedly improved by the treatment of 18 cases, 56. 25% ; Effective in 12 cases, 37. 50% ; 1 ease ineffective, accounted for 3. 13% ; 1 case death, accounting for 3. 13%. The total effective rate 93.75%. Before and after treatment pH value difference in no statistical significance （P 〉 0. 05） ; PaCO2, PaO2 compared before and after treatment （ P 〈 0. 05）. Conclusion ： Pulmonary cerebral mixture treatment of pulmonary eneephalopatby clinical curative effect is distinct, can better improve the clinical symptoms and blood gas analysis condition, and has the characteristics of easy and convenient, suitable for popu- larization and application in basic - level hospitals.

关 键 词：肺脑合剂 基层医院 肺性脑病 

分 类 号：R747.9[医药卫生—神经病学与精神病学]